These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33035112)

  • 1. Fungal Infections in Burn Patients.
    Palackic A; Popp D; Tapking C; Houschyar KS; Branski LK
    Surg Infect (Larchmt); 2021 Feb; 22(1):83-87. PubMed ID: 33035112
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The occurrence of fungi from burn wound patients and antifungal susceptibility patterns: a cross-sectional study in Lusaka, Zambia.
    Sikwewa K; Simusika P; Mumbula M; Mwenya DM; Mandona C; Mulundu G
    Afr Health Sci; 2023 Sep; 23(3):506-513. PubMed ID: 38357155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging infections in burns.
    Branski LK; Al-Mousawi A; Rivero H; Jeschke MG; Sanford AP; Herndon DN
    Surg Infect (Larchmt); 2009 Oct; 10(5):389-97. PubMed ID: 19810827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal infections in burns: Diagnosis and management.
    Capoor MR; Sarabahi S; Tiwari VK; Narayanan RP
    Indian J Plast Surg; 2010 Sep; 43(Suppl):S37-42. PubMed ID: 21321655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the pathogenic characteristics of fungal bloodstream infection in severe burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Shi YL; Liu TF; Li HY; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):37-41. PubMed ID: 32023716
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 9. Developments in the epidemiolgy of invasive fungal infections - implications for the empiric and targeted antifungal therapy.
    Hof H
    Mycoses; 2008; 51 Suppl 1():1-6. PubMed ID: 18471155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Five patients with severe burns complicated by fungal infection].
    Fan YF; Chen C; Li JL; Huang N; Cui SY
    Zhonghua Shao Shang Za Zhi; 2019 Mar; 35(3):221-223. PubMed ID: 30897870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing strategies for the management of invasive fungal infections.
    Rapp RP
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing fungal infections in the intensive care unit.
    De Pauw BE
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S93-6. PubMed ID: 16895517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of culture with histopathology in fungal burn wound colonization and infection.
    Schofield CM; Murray CK; Horvath EE; Cancio LC; Kim SH; Wolf SE; Hospenthal DR
    Burns; 2007 May; 33(3):341-6. PubMed ID: 17321689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
    Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
    Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive fungal infections: a review of epidemiology and management options.
    Enoch DA; Ludlam HA; Brown NM
    J Med Microbiol; 2006 Jul; 55(Pt 7):809-818. PubMed ID: 16772406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antifungal agents.
    Gupta AK; Tomas E
    Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selection of antifungal agents for burn patients].
    Huan JN
    Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):144-7. PubMed ID: 23985202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.